Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload

被引:69
作者
Banerjee, Debasish [1 ]
Ma, Jennie Z.
Collins, Allan J.
Herzog, Charles A.
机构
[1] St Georges Hosp NHS Trust, Renal & Transplantat Unit, London SW17 0QT, England
[2] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA
[3] US Renal Data Syst, Cardiovasc Special Studies Ctr, Minneapolis, MN USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2007年 / 2卷 / 06期
关键词
D O I
10.2215/CJN.01110307
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Mortality in patients who are on maintenance hemodialysis and have congestive heart failure is high in small cohort studies. The aim of this study was to determine long-term survival in a large cohort of dialysis patients with congestive heart failure and suspected fluid overload or pulmonary edema. Design, setting, participants, & measurements: Data were analyzed, retrospectively, on 1,119,808 patients who started hemodialysis between January 1977 and December 1999. Survival was estimated from the first (index) hospital admission with congestive heart failure, fluid overload, or pulmonary edema, after 60 d of successful hemodialysis using the life-table method. The impact of patient characteristics on outcome was assessed by the Cox proportional hazards model. Results: Of the 310,456 patients included in the study, 233,454 were admitted with congestive heart failure, 63,886 with fluid overload, and 13,116 with pulmonary edema. The patients with congestive heart failure were older and often white and had diabetes or hypertension as the cause of renal failure. Deaths during the index hospital admission were 8.7% for congestive heart failure, 4.0% for fluid overload, and 6.6% for pulmonary edema. Five-year survival was 12.5, 20.2, and 21.3%, respectively. The independent positive predictors for mortality in these patients were age, male gender, diabetes, hypertension, history of cardiovascular disease, and congestive heart failure. Conclusions: This study demonstrates very poor survival in dialysis patients who present with congestive heart failure, pulmonary edema, or fluid overload compared with patients who present with congestive heart failure without renal failure. Meticulous management of cardiovascular risk should improve survival.
引用
收藏
页码:1186 / 1190
页数:5
相关论文
共 30 条
  • [1] β-Blocker use in long-term dialysis patients -: Association with hospitalized heart failure and mortality
    Abbott, KC
    Trespalacios, FC
    Agodoa, LY
    Taylor, A
    Bakris, GL
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (22) : 2465 - 2471
  • [2] Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors
    Birman-Deych, E
    Waterman, AD
    Yan, Y
    Nilasena, DS
    Radford, MJ
    Gage, BF
    [J]. MEDICAL CARE, 2005, 43 (05) : 480 - 485
  • [3] PERFUSION THALLIUM IMAGING OF TYPE-I DIABETES PATIENTS WITH END STAGE RENAL-DISEASE - COMPARISON OF ORAL AND INTRAVENOUS DIPYRIDAMOLE ADMINISTRATION
    BOUDREAU, RJ
    STRONY, JT
    DUCRET, RP
    KUNI, CC
    WANG, Y
    WILSON, RF
    SCHWARTZ, JS
    CASTANEDAZUNIGA, WR
    [J]. RADIOLOGY, 1990, 175 (01) : 103 - 105
  • [4] Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy -: A prospective, placebo-controlled trial
    Cice, G
    Ferrara, L
    D'Andrea, A
    D'Isa, S
    Di Benedetto, A
    Cittadini, A
    Russo, PE
    Golino, P
    Calabrò, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (09) : 1438 - 1444
  • [5] Dilated cardiomyopathy in dialysis patients - Beneficial effects of carvedilol: A double-blind, placebo-controlled trial
    Cice, G
    Ferrara, L
    Di Benedetto, A
    Russo, PE
    Marinelli, G
    Pavese, F
    Iacono, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 407 - 411
  • [6] Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study
    Cice, G
    Tagliamonte, E
    Ferrara, L
    Iacono, A
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 (15) : 1259 - 1264
  • [7] Cardiovascular disease in end-stage renal disease patients
    Collins, AJ
    Li, SL
    Ma, JZ
    Herzog, C
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S26 - S29
  • [8] Foley RN, 2000, J AM SOC NEPHROL, V11, P912, DOI 10.1681/ASN.V115912
  • [9] FOLEY RN, 1995, J AM SOC NEPHROL, V5, P2024
  • [10] CLINICAL AND ECHOCARDIOGRAPHIC DISEASE IN PATIENTS STARTING END-STAGE RENAL-DISEASE THERAPY
    FOLEY, RN
    PARFREY, PS
    HARNETT, JD
    KENT, GM
    MARTIN, CJ
    MURRAY, DC
    BARRE, PE
    [J]. KIDNEY INTERNATIONAL, 1995, 47 (01) : 186 - 192